Cardiovascular risk assessment has long carried a blind spot: the tools clinicians use were built on older populations and ignore the biological events that unfold during and after pregnancy. For women in their 20s and 30s, this gap can mean silent cardiovascular risk accumulates undetected for decades — until it is too late to intervene early.
Drawing on a cohort of nearly 263,000 women aged 15 to 45 from the UK's Clinical Practice Research Datalink, researchers developed a postpartum cardiovascular risk model that deliberately incorporates female-specific biology. Using LASSO variable selection and an accelerated failure time Weibull regression framework, the model identified a rich predictor set that extends well beyond traditional lipids-and-blood-pressure risk factors. Final predictors included polycystic ovary syndrome, prior oral contraceptive use, depression, thyroid disorders, hypertensive disorders of pregnancy, gestational diabetes, preterm birth, small-for-gestational-age birthweight, parity, prior pregnancy complications, and social deprivation. Over a median follow-up of roughly 3.8 years, 943 incident cardiovascular events occurred — a rate of 0.81 per 1,000 person-years — providing the outcome data needed to calibrate a model tuned to this younger, lower-absolute-risk population.
This work sits at the intersection of two converging research streams: the growing recognition that adverse pregnancy outcomes (APOs) are legitimate cardiovascular risk markers, and the longstanding critique that general-population risk scores — Framingham, SCORE2, PCE — systematically misclassify younger women. The model's inclusion of social deprivation reflects accumulating evidence that socioeconomic stress is an independent cardiovascular driver, not merely a confounder. Key limitations include the reliance on internal bootstrapped validation rather than a fully independent external cohort, the relatively short median follow-up for a chronic disease endpoint, and the UK-specific primary care database, which may limit generalizability to other healthcare systems. Whether the model's discrimination holds in ethnically diverse populations warrants prospective testing. If externally validated, a postpartum screening tool of this kind could reframe the first-year check-up as a meaningful cardiovascular triage window — potentially one of the earliest opportunities to stratify long-term risk in women.